- Anatomy Of The National Drug Code
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- Will The FDA Delay The DSCSA?
- Global Traceability Data Exchange: Troubled Waters Ahead
- Pharma Serialization: Going Totally Global Soon
- Will The DSCSA Cause Drug Shortages After January 1?
- DSCSA: Transaction Statement
Archive for the ‘Supply Network Blog’ Category
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
Been following RxTrace ever since some of the very first postings, and it’s one of my absolutely best sources of serious and thorough analyses, on an otherwise very delicate and complicated topic. Dirk’s writings and articles comes highly recommended, and I’m always looking forward to the next posting. Many thanks from Denmark for sharing your thoughts with us all.
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
The knowledge presented in RxTrace, not simply the more common focus of the manufacturing, packaging, and regulatory requirements, but Dirk’s wholesale experience provides him with a complex view on the impacts to the end-to-end supply chain.
RxTrace distills the complexities of pharmaceutical supply chain issues to simple concepts and also accurately projects issues on the horizon that industry leaders and legislators should heed.
RxTrace offers unique context and focus on our industry.
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
Look forward to RxTrace News-helps me to better manage key issues
December 5, 2014 (6:00)
Will The DSCSA Cause Drug Shortages After January 1?I wonder how a manufacturer could develop a single data exchange system for a...
December 1, 2014 (8:37)
The Coming Transition To Serialized DataVERY good and constructive analysis. In a timely manner, once more.... Thx......
November 26, 2014 (11:02)
The DSCSA, the NDC, Inventory Management, GS1 GTINs...and TurkeysGreat news! Obama was looking for a legacy. HR 3204 can be it!
November 17, 2014 (3:30)
Will The DSCSA Cause Drug Shortages After January 1?Dirk, You have stated well the conundrum that Wholesaler Distributors face i...
November 1, 2014 (9:15)
The GS1 Healthcare US Guidance For DSCSA, Vsn 1.1The US law requires a verification based process when suspect product occurs....